Inhibrx Institutional ownership
What is the Institutional ownership of Inhibrx?
The Institutional ownership of Inhibrx, Inc. is 80.27%
What is the definition of Institutional ownership?
Institutional Ownership is the amount of a company’s available stock owned by mutual or pension funds, insurance companies, investment firms, endowments or other large entities that manage funds on the behalf of others.
Given the considerable sums of money that institutions invest, it is not surprising that they tend to be much more knowledgeable than the average investor when it comes to the companies and industries in which they have invested.
Institutional portfolio managers often meet personally with a company's top executives, and in many cases the research they conduct is further supported by equity analysts who evaluate prospective companies and industries in great depth before making specific investment recommendations.
Institutional ownership of companies in the Health Care sector on NASDAQ compared to Inhibrx
What does Inhibrx do?
Inhibrx, Inc., a clinical-stage biotechnology company, focuses on developing a pipeline of novel biologic therapeutic candidates. The company's therapeutic candidates include INBRX-109, a tetravalent agonist of death receptor 5, which is in Phase 2 clinical trials to treat cancers, such as chondrosarcoma, mesothelioma, and pancreatic adenocarcinoma; INBRX-105, a tetravalent conditional agonist of programmed death-ligand 1 and a conditional agonist of 4-1BB that is in Phase 1 clinical trials to treat patients with locally advanced or metastatic solid tumors; and INBRX-101, an alpha-1 antitrypsin (AAT)-Fc fusion protein therapeutic candidate, which is in Phase 1 clinical trials for use in the treatment of patients with AAT deficiency. It also provides INBRX-106, a hexavalent agonist of OX40 for a range of oncology indications. The company was founded in 2010 and is headquartered in La Jolla, California.
Companies with institutional ownership similar to Inhibrx
- Stock Spirits Plc has Institutional ownership of 80.16%
- SVMK Inc has Institutional ownership of 80.18%
- Freeport-McMoRan Inc has Institutional ownership of 80.20%
- Marathon Oil has Institutional ownership of 80.20%
- ULS Technology plc has Institutional ownership of 80.22%
- Target Corp has Institutional ownership of 80.26%
- Inhibrx has Institutional ownership of 80.27%
- Marathon Oil has Institutional ownership of 80.28%
- Marathon Oil has Institutional ownership of 80.28%
- BlackRock has Institutional ownership of 80.28%
- BlackRock has Institutional ownership of 80.28%
- RCF Acquisition has Institutional ownership of 80.29%
- Carriage Services has Institutional ownership of 80.29%